# Add-on Dextromethorphan in Bipolar Disorders

> **NCT01188265** · PHASE3 · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 300 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Valproate
- **DRUG:** Dextromethorphan 60 mg per day
- **DRUG:** Placebo
- **DRUG:** Dextromethorphan 30 mg

## Key facts

- **NCT ID:** NCT01188265
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-12
- **Final completion:** 2011-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2013-09-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01188265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01188265, "Add-on Dextromethorphan in Bipolar Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01188265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*